Browsing Centre for Genomics and Child Health by Author "Abhishek, A"
Now showing items 1-2 of 2
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek, A; Peckham, N; Pade, C; Gibbons, JM; Cureton, L; Francis, A; Barber, V; Williams, JAE; Appelbe, D; Eldridge, L (2024-02)BACKGROUND: Methotrexate is the first-line treatment for immune-mediated inflammatory diseases and reduces vaccine-induced immunity. We evaluated if a 2-week interruption of methotrexate treatment immediately after COVID-19 ... -
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek, A; Boyton, RJ; Peckham, N; McKnight, A; Coates, LC; Bluett, J; Barber, V; Cureton, L; Francis, A; Appelbe, D (2022)